Dr. Lin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 Bank of America
# 365
Los Angeles, CA 90074Phone+1 310-825-6301
Education & Training
- University of California (San Diego) Medical CenterFellowship, Rheumatology, 2000 - 2003
- Scripps Clinic/Scripps Green HospitalFellowship, Allergy and Immunology, 1999 - 2002
- University of Texas Southwestern Medical CenterResidency, Internal Medicine, 1997 - 1999
- Johns Hopkins University School of MedicineClass of 1995
Certifications & Licensure
- CA State Medical License 1999 - 2025
- NY State Medical License 2002 - 2025
- TX State Medical License 1997 - 2023
Publications & Presentations
PubMed
- 258 citationsA Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of Brodalumab in Patients With Moderate-to-Severe Crohn's Disease.Stephan R. Targan, Brian G. Feagan, Severine Vermeire, Remo Panaccione, Gil Y. Melmed
The American Journal of Gastroenterology. 2016-08-02 - 56 citationsA Study to Evaluate the Safety, Tolerability, and Efficacy of Brodalumab in Subjects with Rheumatoid Arthritis and an Inadequate Response to MethotrexateKarel Pavelka, Yun Chon, Richard Newmark, Shao-Lee Lin, Scott Baumgartner
The Journal of Rheumatology. 2015-04-15 - 398 citationsRadiographic progression of ankylosing spondylitis after up to two years of treatment with etanerceptD. van der Heijde, Robert Landewé, S. Einstein, P Ory, D Vosse
Arthritis and Rheumatism. 2008-05-01
Press Mentions
- ACELYRIN Acquires ValenzaBio, Strengthens Immunology PositionJanuary 6th, 2023
- Integrated Clinical Trial Analyses Further Substantiate That Teprotumumab Significantly Improves Debilitating Effects of Thyroid Eye Disease, Including Eye Bulging, Double Vision and Quality of LifeOctober 31st, 2019
- American Journal of Ophthalmology (AJO) Publishes Review Highlighting Lack of Treatments for Active Thyroid Eye Disease (TED)August 19th, 2019
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: